Retinoblastoma caused by an RB1 variant with unusually low penetrance in a Danish family

Retinoblastoma is the most common eye cancer in children. It is caused by pathogenic alterations of both alleles of the tumor suppressor gene RB1. In heritable retinoblastoma, a constitutional RB1 variant predisposes the cells to tumor formation, and loss of the other allele is a prerequisite for th...

Full description

Saved in:
Bibliographic Details
Published in:European journal of medical genetics 2024-08, Vol.70, p.104956, Article 104956
Main Authors: Gregersen, Pernille A., Jensen, Peter S., Christensen, Rikke, Lohmann, Dietmar, Racher, Hilary, Gallie, Brenda, Urbak, Steen F.
Format: Article
Language:English
Subjects:
Genetic counseling
RB1
Reduced penetrance
Retinoblastoma
Tumor DNA
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Retinoblastoma is the most common eye cancer in children. It is caused by pathogenic alterations of both alleles of the tumor suppressor gene RB1. In heritable retinoblastoma, a constitutional RB1 variant predisposes the cells to tumor formation, and loss of the other allele is a prerequisite for the development of retinoblastoma. Heritable retinoblastoma is inherited in an autosomal dominant manner; however, the majority of cases are the result of a de novo pathogenic RB1 variant. Penetrance is usually high (>90%), but with marked inter-familial variability. In some families, penetrance is incomplete and family members who develop tumors tend to remain unilaterally affected. Moreover, some families with low penetrance also show a parent-of-origin effect. We describe a patient with unilateral retinoblastoma caused by a previously unreported likely pathogenic RB1 variant (c.1199T>C) that disrupts a highly conserved amino acid residue within the A-box functional domain. Segregation analysis showed that the variant had unusually low penetrance as nine non-affected family members carried the same variant. We emphasize the use of genetic analysis on tumor DNA for classifying the RB1 variant, and underline the challenges in clinical management and counseling of families carrying the specific RB1 variant.
ISSN:1769-7212
1878-0849
1878-0849
DOI:10.1016/j.ejmg.2024.104956